Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

High-Fiber Plant-Based Diet May Be Beneficial for Monoclonal Gammopathy, Multiple Myeloma

A high-fiber plant-based diet (HFPBD) can be beneficial for patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myel

How Do Low-Calorie Diets Affect A Person's Mood?

WEDNESDAY, June 4, 2025 Counting calories isn t simply a bummer, it might actually increase your risk of depression, a new study says.People on low-calorie diet

High Insulin Linked To Irregular Periods

WEDNESDAY, June 4, 2025 Elevated insulin levels could be causing irregular menstrual bleeding in women, a new study says.Women with excess levels of insulin are

Coffee Could Be Key To Aging Gracefully

WEDNESDAY, June 4, 2025 A morning cup of coffee might do more than momentarily boost your energy and spirits.Full-test java also appears to help women age more

Pepto Bismol May Not Prevent Traveler’s Diarrhea, New Study Finds

WEDNESDAY, June 4, 2025 Pepto Bismol is a go-to stomach remedy, but a new study suggests it might not help prevent diarrhea during international travel.The stud

Judge Says Transgender Inmates Must Have Access to Hormone Therapy

WEDNESDAY, June 4, 2025 A federal judge has ruled that transgender inmates in U.S. prisons must continue getting medical care, including hormone therapy and gen

Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome

Autism Spectrum Disorder Linked to Increased Risk for Parkinson Disease

Autism spectrum disorder (ASD) is associated with an increased risk for Parkinson disease (PD), according to a study published online May 27 in JAMA Neurology.W

Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology.Kevin T. Liou,

Early Results from Johnson & Johnson’s Trispecific Antibody JNJ-5322 Show Promising Response in Heavily Pretreated Multiple Myeloma Patients

Chicago (June 3, 2025) Johnson Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) i

Popular Keywords